Executive Summary

The World Health Organization has named the COVID-19 outbreak associated with transmission of the novel coronavirus SARS-CoV-2 a global pandemic. First reported from Wuhan, China, in December 2019, the virus has rapidly spread across continents, and is a potent economic threat as well as a public health crisis.

All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should be assessing their preparedness and identifying antimicrobial products effective against SARS-CoV-2. The U.S. Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which aerosol-generating procedures are performed. Refer to List N on the EPA website for EPA-registered disinfectants that have qualified under EPA's emerging viral pathogens program for use against SARS-CoV-2.

On March 3, 2020, the U.S. Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. EPA updated this list on April 16, 2020. Manufacturers of reusable, noncritical medical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table listing the disinfectant concentrations and contact times for products in List N. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update List N, we will update our table as needed.

Who Should Read This

Table of Contents

Overview

The World Health Organization has named the COVID-19 outbreak associated with transmission of the novel coronavirus SARS-CoV-2 a global pandemic. First reported from Wuhan, China, in December 2019, the virus has rapidly spread across continents, and is a potent economic threat as well as a public health crisis.

All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should be assessing their preparedness and identifying antimicrobial products effective against SARS-CoV-2. The U.S. Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which aerosol-generating procedures are performed. Refer to List N on the EPA website for EPA-registered disinfectants that have qualified under EPA's emerging viral pathogens program for use against SARS-CoV-2.

On March 3, 2020, the U.S. Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. EPA updated this list on April 16, 2020. Manufacturers of reusable, noncritical medical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table listing the disinfectant concentrations and contact times for products in List N. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update List N, we will update our table as needed.
 

Download the Table

Disinfectant Concentrations and Contact Times for Products Effective against Novel Coronavirus SARS-CoV-2

Glossary

Bibliography

References

Chamber of Commerce, U.S. Quick take: coronavirus' economic impact [online]. 2020 Apr 3 [cited 2020 Apr 23]. Available from: https://www.uschamber.com/series/above-the-fold/quick-take-coronavirus-economic-impact.

Centers for Disease Control and Prevention (CDC), U.S. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings [online]. 2020 Apr 13 [cited 2020 Apr 23]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Finfection-control.html.

Environmental Protection Agency (EPA), U.S. List N: Disinfectants for use against SARS-CoV-2 [online]. 2020 Apr 16 [cited 2020 Apr 23]. Available from: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2.

Topics and Metadata

Topics

Biomedical Engineering; Infection Control; Laws, Regulations, Standards; Long-term Care; Procurement Trends; Quality Assurance/Risk Management; Sterilization and Reprocessing; Physician Preference Items; Technology Management; Inventory Management; Service and Maintenance; Technology Selection; Transitions of Care

Caresetting

Ambulatory Care Center; Ambulatory Surgery Center; Assisted-living Facility; Behavioral Health Facility; Dialysis Facility; Emergency Department; Endoscopy Facility; Home Care; Hospice; Hospital Inpatient; Hospital Outpatient; Imaging Center; Independent Living Facility; Physician Practice; Rehabilitation Facility; Short-stay Facility; Skilled-nursing Facility; Substance Abuse Treatment Facility; Trauma Center

Clinical Specialty

Bariatrics; Critical Care; Emergency Medicine; Hospital Medicine; Internal Medicine; Obstetrics; Oncology; Primary Care; Surgery; Transplantation

Roles

Allied Health Personnel; Biomedical/Clinical Engineer; Clinical Practitioner; Environmental Services Manager; Infection Preventionist; Materials Manager/Procurement Manager; Patient Safety Officer; Quality Assurance Manager; Regulator/Policy Maker; Risk Manager

Information Type

Guidance

Phase of Diffusion

 

Technology Class

 

Clinical Category

 

SourceBase Supplier

Product Catalog

MeSH

ICD9/ICD10

FDA SPN

SNOMED

HCPCS

Disease/Condition

 

Publication History